Richard D. Francis

Richard D. Francis (board member) discloses dealings in 2 companies, chiefly Teva Pharmaceutical Industries Ltd and Mettler Toledo International Inc/. In total, 13 filings cover trades dated from 4 November 2021 to 5 March 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 9 March 2026 with an option exercise in Teva Pharmaceutical Industries Ltd. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.